H. Curcio

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial

Jordi Remón, Benjamin Besse, Santiago Ponce Aix et al. · Annals of Oncology · 2023 · 73 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%

Elvire Pons‐Tostivint, P. Hulo, V. Guardiolle et al. · Cancer Immunology Immunotherapy · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +7

LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.

Aurélie Swalduz, H. Curcio, Bana Ambasager et al. · Journal of Clinical Oncology · 2023 · 14 citations

Medicine, Molecular Medicine, Oncology +17